Restart Life Sciences Corp.
HEAL
株式のランク
#35835
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
株価
$0.05137558
最終同期: 2026-10-16
時価総額
$3.21M
変化（1日）
0.00%
変化（1年）
78.84%
国
CA
取引 Restart Life Sciences Corp. (HEAL)
カテゴリー
Healthcare
の時価総額 Restart Life Sciences Corp.(HEAL)
時価総額: $3.21M
October 2026時点で、Restart Life Sciences Corp. の時価総額は $3.21M です。これは、当社のデータによると、Restart Life Sciences Corp. が世界で35835th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Restart Life Sciences Corp. の時価総額の履歴（2006 から 2026 まで）
